首页> 美国卫生研究院文献>Oncology Letters >MicroRNA-218 inhibits the cell proliferation and migration in clear cell renal cell carcinoma through targeting cancerous inhibitor of protein phosphatase 2A
【2h】

MicroRNA-218 inhibits the cell proliferation and migration in clear cell renal cell carcinoma through targeting cancerous inhibitor of protein phosphatase 2A

机译:MicroRNA-218通过靶向蛋白磷酸酶2A的癌性抑制剂抑制透明细胞肾细胞癌中的细胞增殖和迁移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNAs (miRs) have emerged as critical modulators of tumor initiation and progression in numerous types of human cancer, including clear cell renal cell carcinoma (ccRCC), which is the most common subtype of renal cell carcinoma. Cancerous inhibitor of protein phosphatase 2A (CIP2A) is a newly characterized oncoprotein and its overexpression has been reported to promote cellular epithelial-mesenchymal transition and the tumor progression of ccRCC. The present study examined the effects of miR-218 on CIP2A expression in ccRCC cells. The results demonstrated that the expression level of miR-218 was lower in ccRCC tissues compared with that in adjacent non-tumor renal tissues. In addition, it was identified that miR-128 could directly bind to the 3′-untranslated region of CIP2A. Furthermore, a negative correlation between the expression levels of miR-218 and CIP2A was detected in ccRCC. Additionally, the downregulation of CIP2A or overexpression of miR-218 in ccRCC cells was revealed to inhibit cell proliferation and migration. In summary, these data suggest that miR-218 serves a role in the regulation of CIP2A and elucidate its consequences on tumor progression, tumor cell proliferation and migration. These results indicate that miR-218 may exhibit potential as a molecular target for the treatment of ccRCC.
机译:在许多类型的人类癌症中,MicroRNA(miRs)已成为肿瘤起始和进展的关键调节剂,其中包括透明细胞肾细胞癌(ccRCC),这是肾细胞癌的最常见亚型。蛋白磷酸酶2A(CIP2A)的癌性抑制剂是一种新近鉴定的癌蛋白,据报道其过度表达可促进细胞上皮-间质转化和ccRCC的肿瘤进展。本研究检查了miR-218对ccRCC细胞中CIP2A表达的影响。结果表明,与邻近的非肿瘤肾组织相比,ccRCC组织中的miR-218表达水平更低。另外,已确定miR-128可直接结合至CIP2A的3'-非翻译区。此外,在ccRCC中检测到miR-218和CIP2A的表达水平呈负相关。此外,揭示了ccRCC细胞中CIP2A的下调或miR-218的过表达抑制了细胞的增殖和迁移。总之,这些数据表明,miR-218在CIP2A的调节中发挥作用,并阐明其对肿瘤进展,肿瘤细胞增殖和迁移的影响。这些结果表明,miR-218可能显示出作为治疗ccRCC的分子靶标的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号